Order Article Reprints

Overholser J, Ambegaokar KH, Eze SM, Sanabria-Figueroa E, Nahta R, Bekaii-Saab T, Kaumaya PTP. Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC). Vaccines. 2015; 3(3):519-543. https://doi.org/10.3390/vaccines3030519

Overholser, Jay, Kristen Henkins Ambegaokar, Siobhan M. Eze, Eduardo Sanabria-Figueroa, Rita Nahta, Tanios Bekaii-Saab, and Pravin T.P. Kaumaya. 2015. "Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC)" Vaccines 3, no. 3: 519-543. https://doi.org/10.3390/vaccines3030519

Overholser, J., Ambegaokar, K. H., Eze, S. M., Sanabria-Figueroa, E., Nahta, R., Bekaii-Saab, T., & Kaumaya, P. T. P. (2015). Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC). Vaccines, 3(3), 519-543. https://doi.org/10.3390/vaccines3030519